Immunoglobulin G subclass deficiency and infection risk in 150 patients with chronic lymphocytic leukemia.
about
Challenges in the Role of Gammaglobulin Replacement Therapy and Vaccination Strategies for Hematological MalignancyPrimary vs. secondary antibody deficiency: clinical features and infection outcomes of immunoglobulin replacement.Cytokine-driven loss of plasmacytoid dendritic cell function in chronic lymphocytic leukemiaImmunoglobulin replacement therapy in secondary hypogammaglobulinemiaAntibody and plasmablast response to 13-valent pneumococcal conjugate vaccine in chronic lymphocytic leukemia patients--preliminary report.Hypogammaglobulinemia in newly diagnosed chronic lymphocytic leukemia: Natural history, clinical correlates, and outcomes.Partial reconstitution of humoral immunity and fewer infections in patients with chronic lymphocytic leukemia treated with ibrutinib.A review of supportive care and recommended preventive approaches for patients with chronic lymphocytic leukemia.Prophylactic immunoglobulin therapy in secondary immune deficiency - an expert opinion.Host virus and pneumococcus-specific immune responses in high-count monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia: implications for disease progression.Facilitated subcutaneous immunoglobulin administration (fSCIg): a new treatment option for patients with secondary immune deficiencies.Hypogammaglobulinemia in newly diagnosed chronic lymphocytic leukemia is a predictor of early death.Secondary Hemophagocytic Syndrome Associated with Richter's Transformation in Chronic Lymphocytic Leukemia.Clinical significance of serum immunoglobulin G subclass deficiency in patients with chronic lymphocytic leukemia.Clinical profile associated with infections in patients with chronic lymphocytic leukemia. Protective role of immunoglobulin replacement therapy.Answer to "Letter to the Editor, Scandinavian Journal of Infectious Diseases".Natalizumab treatment decreases serum IgM and IgG levels in multiple sclerosis patients.Blood biomarkers in adults with lymph node enlargement contribute to diagnostic significance of malignancy.Favorable immune signature in CLL patients, defined by antigen-specific T-cell responses, might prevent second skin cancers.Antibodies against Pneumococcal Capsular Polysaccharides and Natural Anti-Galactosyl (Alpha-Gal) in Patients with Humoral Immunodeficiencies.The Clinical Utility of Measuring IgG Subclass Immunoglobulins During Immunological Investigation for Suspected Primary Antibody Deficiencies.The clinical significance of hypogammaglobulinaemia and serum immunoglobulin G subclass deficiency in patients with chronic lymphocytic leukaemia (CLL).A review of the infection pathogenesis and prophylaxis recommendations in patients with chronic lymphocytic leukemia.
P2860
Q28080304-D319BDB0-1516-4D38-9709-98C8EC1DAE55Q33817252-02F826D9-384B-4E8B-87C6-7FD4F9EC5AEEQ33910990-F80FC568-4DD4-41E9-B3AF-44EBBAD2AE47Q34652046-EE8ED618-AB1A-41D5-8210-22214F77DBB5Q34704085-E33F7072-AE7F-408D-AC0E-5241E3348247Q35985600-059E0D70-91B8-4791-831A-AD741F295D38Q36253983-10C1587A-4631-4F9D-AE15-B8AF4A4F53B6Q38664705-709B742C-EEBB-4B1E-9286-DBB822E3AF27Q38896505-330B1524-62E5-48C7-BB60-B9678B6C4A19Q40254202-573B10E2-95F6-463B-8A1D-11343EBE50BDQ40683402-8FBB12F9-A1AB-4904-9784-7A31DEFA5C8BQ40802888-86CF1AB8-5923-407D-955C-B51EC3579A32Q41863172-D0EAD0BA-BB8E-4115-BB7C-8417FEECD758Q42274119-2C6D4430-3F00-4094-A63D-79BD011F865FQ43146945-FE4EAC39-92D3-4A44-B45C-4479AC5408EAQ43597348-908ABE34-DDAA-4290-9EF8-047B3FF5F749Q44938493-AA0E635A-3FBF-4543-97F5-0D21C410657EQ47164637-75EF312F-401F-4A54-8574-8C7576AD7D87Q47218376-B293CA6C-590B-4C19-B9B0-D8B18E37BE6DQ47552836-2243E8B2-63AF-4732-80A8-DA02A083FDF8Q48604570-1246A538-3AA1-4615-BFF0-519B0619F281Q50858307-ABA9CBCE-6581-483B-BDBB-F03810335592Q52776107-E0521E33-B826-47B7-9B8B-071B1CF0AEF4
P2860
Immunoglobulin G subclass deficiency and infection risk in 150 patients with chronic lymphocytic leukemia.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Immunoglobulin G subclass defi ...... chronic lymphocytic leukemia.
@en
Immunoglobulin G subclass defi ...... chronic lymphocytic leukemia.
@nl
type
label
Immunoglobulin G subclass defi ...... chronic lymphocytic leukemia.
@en
Immunoglobulin G subclass defi ...... chronic lymphocytic leukemia.
@nl
prefLabel
Immunoglobulin G subclass defi ...... chronic lymphocytic leukemia.
@en
Immunoglobulin G subclass defi ...... chronic lymphocytic leukemia.
@nl
P2093
P2860
P1433
P1476
Immunoglobulin G subclass defi ...... h chronic lymphocytic leukemia
@en
P2093
Cecily J Forsyth
Jane A Freeman
Kyle R Crassini
Naomi J Mackinlay
Stephen P Mulligan
William Stevenson
P2860
P304
P356
10.3109/10428194.2012.706285
P50
P577
2012-09-08T00:00:00Z